We are live on !
Find out more
DMK
David M. Knott Portfolio holdings
AUM
$275M
Turnover
23.21%
1-Year Est. Return
59.23%
This Fund
S&P 500
This Quarter Est. Return
+4.17%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$481M
AUM Growth
–
Cap. Flow
+$471M
Cap. Flow % of AUM
Cap. Flow %
98.11%
Top 10 Holdings %
Top 10 Hldgs %
52.66%
Holding
70
New
69
Increased
–
Reduced
–
Closed
–
Avg Time Held
0
years
Top 10 Avg Time Held
0
years
Top 20 Avg Time Held
0
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ligand Pharmaceuticals
LGND
|
+$41.9M |
| 2 |
Pfizer
PFE
|
+$37.8M |
| 3 |
Anadarko Petroleum
APC
|
+$31.9M |
| 4 |
SLB Ltd
SLB
|
+$21.5M |
| 5 |
NBL
Noble Energy, Inc.
NBL
|
+$19.1M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 67.09% |
| 2 | Healthcare | 19.62% |
| 3 | Financials | 2.32% |
| 4 | Industrials | 2.14% |
| 5 | Real Estate | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Ligand Pharmaceuticals
LGND
$6.29B
| $54.3M | 11.3% |
+2,328,463
| New | +$41.9M |
2013 Q2
0 quarters
|
|
|
2
Pfizer
PFE
$168B
| $36.4M | 7.57% |
+1,368,594
| New | +$37.8M |
2013 Q2
0 quarters
|
|
|
3
DELISTED
Anadarko Petroleum
APC
| $31.8M | 6.62% |
+370,350
| New | +$31.9M |
2013 Q2
0 quarters
|
|
|
4
SLB Ltd
SLB
$74.6B
| $20.8M | 4.32% |
+290,000
| New | +$21.5M |
2013 Q2
0 quarters
|
|
|
NBL
5
DELISTED
Noble Energy, Inc.
NBL
| $19.8M | 4.12% |
+330,000
| New | +$19.1M |
2013 Q2
0 quarters
|
|
6
DELISTED
Pioneer Natural Resource Co.
PXD
| $18.8M | 3.92% |
+130,000
| New | +$17.4M |
2013 Q2
0 quarters
|
|
7
Halliburton
HAL
$26.3B
| $18.8M | 3.91% |
+450,000
| New | +$18.8M |
2013 Q2
0 quarters
|
|
|
WLL
8
DELISTED
Whiting Petroleum Corporation
WLL
| $18.4M | 3.84% |
+1,334
| New | +$18.6M |
2013 Q2
0 quarters
|
|
9
SM Energy
SM
$6.81B
| $18M | 3.74% |
+300,000
| New | +$18.3M |
2013 Q2
0 quarters
|
|
|
CXO
10
DELISTED
CONCHO RESOURCES INC.
CXO
| $15.9M | 3.31% |
+190,000
| New | +$16.2M |
2013 Q2
0 quarters
|
|
11
TechnipFMC
FTI
$24.7B
| $14.5M | 3.01% |
+349,440
| New | +$14.3M |
2013 Q2
0 quarters
|
|
12
DELISTED
Coterra Energy
CTRA
| $14.2M | 2.96% |
+400,000
| New | +$13.8M |
2013 Q2
0 quarters
|
|
13
DELISTED
Hess
HES
| $13.3M | 2.77% |
+200,000
| New | +$13.8M |
2013 Q2
0 quarters
|
|
|
WPX
14
DELISTED
WPX Energy, Inc.
WPX
| $12.7M | 2.64% |
+670,000
| New | +$12M |
2013 Q2
0 quarters
|
|
15
Helmerich & Payne
HP
$3.52B
| $12.2M | 2.53% |
+195,000
| New | +$12M |
2013 Q2
0 quarters
|
|
16
DELISTED
Noble Corporation
NE
| $12M | 2.5% |
+366,080
| New | +$12.2M |
2013 Q2
0 quarters
|
|
17
Canadian Natural Resources
CNQ
$97B
| $11.6M | 2.42% |
+852,138
| New | +$12.2M |
2013 Q2
0 quarters
|
|
|
XEC
18
DELISTED
CIMAREX ENERGY CO
XEC
| $11M | 2.3% |
+170,000
| New | +$12.1M |
2013 Q2
0 quarters
|
|
19
NOV
NOV
$6.34B
| $9.6M | 2.01% |
+155,260
| New | +$9.6M |
2013 Q2
0 quarters
|
|
20
Capitol Federal Financial
CFFN
$1.07B
| $9.06M | 1.88% |
+745,600
| New | +$8.89M |
2013 Q2
0 quarters
|
|
|
AREX
21
DELISTED
Approach Resources Inc.
AREX
| $8.72M | 1.82% |
+355,000
| New | +$8.87M |
2013 Q2
0 quarters
|
|
|
RLOG
22
DELISTED
Rand Logistics, Inc.
RLOG
| $8.3M | 1.73% |
+1,617,657
| New | +$9.06M |
2013 Q2
0 quarters
|
|
23
Future Fuel
FF
$223M
| $8.07M | 1.68% |
+569,187
| New | +$7.63M |
2013 Q2
0 quarters
|
|
24
DELISTED
Southwestern Energy Company
SWN
| $7.67M | 1.6% |
+210,000
| New | +$7.8M |
2013 Q2
0 quarters
|
|
25
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
| $7.34M | 1.53% |
+120,000
| New | +$7.46M |
2013 Q2
0 quarters
|
|
Similar funds
FA
KCP
HCIA
DCM
MCL
David M. Knott's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for David M. Knott, which disclosed 70 positions worth $481M. Its ten largest holdings account for 53% of the portfolio.
Its largest position is Ligand Pharmaceuticals: 2,328,463 shares worth $54.3M.
By sector, the portfolio is most concentrated in Energy at 67% of assets, followed by Healthcare and Financials.
- David M. Knott's largest Q2 2013 buy was Ligand Pharmaceuticals: 2,328,463 shares worth $54.3M.
- David M. Knott's ten largest holdings make up 53% of its $481M portfolio in Q2 2013.
- David M. Knott disclosed 70 positions in Q2 2013, its first 13F filing on record.
Based on David M. Knott's 13F filing for Q2 2013, filed 13 Aug 2013.